Maxine Bennett

Efficacy and cost of video-assisted thoracoscopic partial pleurectomy versus talc pleurodesis in patients with malignant pleural mesothelioma (MesoVATS): an open-label, randomised, controlled trial

Robert C. Rintoul, Andrew J. Ritchie, John Edwards et al. · The Lancet · 2014 · 218 citations

Surgical Oncology, Malignant Pleural Mesothelioma, Pleural Effusion +6

A crossover randomised controlled trial of oral mandibular advancement devices for obstructive sleep apnoea-hypopnoea (TOMADO)

Timothy Quinnell, Maxine Bennett, Jake Jordan et al. · Thorax · 2014 · 94 citations · Full text

Clinical effectiveness and cost-effectiveness results from the randomised controlled Trial of Oral Mandibular Advancement Devices for Obstructive sleep apnoea–hypopnoea (TOMADO) and long-term economic analysis of oral devices and continuous positive airway pressure

Linda Sharples, Matthew Glover, Abigail Clutterbuck-James et al. · Health Technology Assessment · 2014 · 61 citations · Full text

Patient-Reported Outcomes Assessed by the CAMPHOR Questionnaire Predict Clinical Deterioration in Idiopathic Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension

Colm McCabe, Maxine Bennett, Natalie Doughty et al. · CHEST Journal · 2013 · 59 citations · Full text

Hypertension, Patient-reported Outcomes, Pulmonary Arterial Hypertension +7

Abstract GS3-02: GS3-02 Camizestrant, a next generation oral SERD vs fulvestrant in post-menopausal women with advanced ER-positive HER2-negative breast cancer: Results of the randomized, multi-dose Phase 2 SERENA-2 trial

Mafalda Oliveira, Denys Pominchuck, Zbigniew Nowecki et al. · Cancer Research · 2023 · 59 citations

Breast Oncology, Multi-dose Phase 2, Gynecology +17